2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC3676
  



  

  
Submitter : 
  

  
Mrs. Kelly Perrault
  

  
Date & Time: 
  

  
12/19/2006 09:12:37
  



  

  
Organization : 
  

  
Mrs. Kelly Perrault
  



  

  
Category : 
  

  
Individual Consumer
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 I am asking the FDA to issue guidelines to pharmaceutical companies to restrict the use of stem cells to those lines established from sources other than fetal tissue from aborted babies.

It only makes sense to utilize non-objectionable lines in vaccine production so all people can benefit from them without compromising their moral beliefs and pro-life convictions. Since there is an abundance of ethical sources, the use of aborted fetal tissue is not necessary.